Press Releases
National Labor Union Apologizes for False and Defamatory Mass Mailing SUTTER HEALTH
A large, national labor union will pay Sutter Health $6 million and has formally apologized for sending false and disparaging postcards to consumers in numerous...
Press Releases
Diamyd Appoints Peter Zerhouni as President Diamyd Medical
Peter Zerhouni has been involved in all aspects of the Company since 2006 and he is since April 2011 Acting President and CEO of the...
Press Releases
Merck Receives Approval to Market GARDASIL®, ZOLINZA® and CUBICIN® in Japan
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved...
Press Releases
CiToxLAB appoints Paul C. Barrow as director of scientific projects and client consulting
CiToxLAB, a leading CRO in the field of non-clinical research, announces today that Paul C. Barrow has joined the company after serving ten years as...
Press Releases
Alkermes Announces Positive Results from Clinical Study of ALKS 9070 For Treatment of Schizophrenia
Alkermes, Inc. (NASDAQ: ALKS) today announced positive topline results from a phase 1b, double-blind, randomized, placebo-controlled study of ALKS 9070 in patients with schizophrenia. ...
Press Releases
Provence Technologies and NexGenix announce successful lead compound development
Provence Technologies, a service provider in fine organic chemistry, and NexGenix Pharmaceuticals, a discovery and development company focused on the "next generation" of targeted therapies...
Press Releases
Adocia launches Phase IIa clinical study on type 1 diabetic patients with its fast-acting human insulin, HinsBet(R)
Adocia SAS, a privately-held biotechnology company specialized in regenerative medicine and in the treatment of chronic diseases, announced today the launch of its second...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.